FIELD: pharmaceutics.
SUBSTANCE: invention relates to a method of producing crystalline epirubicin chloride which is valuable in pharmaceutical industry. Disclosed method comprises: (a) obtaining epirubicin hydrochloride, (b) preparing a mixture which contains obtained epirubicin hydrochloride and at least one alcohol selected from a group consisting of 1-butanol, 2-butanol and 1-pentanol, and (c) crystallisation of hydrochloride epirubicin from said mixture, mixture at step (b) additionally contains water and fraction of epirubicin hydrochloride ranges from 10 to 50 g/l in relation to volume of mixture, and mixture is held at 50-75 °C for at least two hours.
EFFECT: novel efficient method of producing thermally stable crystalline epirubicin.
14 cl, 4 ex, 2 dwg
Title | Year | Author | Number |
---|---|---|---|
STABLE CRYSTALLINE MONOHYDRATE OF HYDROCHLORIDE EPIRUBICIN AND METHOD FOR ITS PRODUCTION | 2014 |
|
RU2630692C2 |
STABLE CRYSTALLINE MONOHYDRATE OF EPIRUBICIN HYDROCHLORIDE AND METHOD FOR PRODUCTION THEREOF | 2017 |
|
RU2700683C2 |
CRYSTALLISATION OF 4′-EPIDAUNORUBICINE X HCI | 2010 |
|
RU2564415C2 |
CRYSTALLINE FORM OF (R)-7-CHLORO-N-(QUINUCLIDIN-3-YL)BENZO[b]THIOPHENE-2-CARBOXAMIDE HYDROCHLORIDE MONOHYDRATE | 2011 |
|
RU2577334C2 |
POLYMORPHIC FORMS OF MACROCYCLIC HCV INHIBITOR | 2008 |
|
RU2533830C2 |
2-[4-(METHYLAMINOMETHYL)PHENYL]-5-FLUORO-BENZOFURAN-7-CARBOXAMIDE HYDROCHLORIDE POLYMORPHOUS, METHOD FOR ITS PRODUCTION AND APPLICATION | 2018 |
|
RU2783418C1 |
POLYMORPHOUS FORM OF LERCANIDIPINE HYDROCHLORIDE AND SYNTHESIS METHOD THEREOF | 2006 |
|
RU2425033C2 |
THERMOSTABLE CRYSTAL EPIRUBICINE HYDROCHLORIDE AND METHOD OF PRODUCTION THEREOF | 2004 |
|
RU2341530C2 |
CRYSTALLINE SOLVATES OF HYDROCHLORIDE 6-(PIPERIDIN-4-YLOXY)-2H-ISOQUINOLIN-1-ONE | 2012 |
|
RU2619129C2 |
REMOVAL OF IMPURITIES FROM EPIDAUNUBRUBICIN | 2015 |
|
RU2662158C2 |
Authors
Dates
2016-06-10—Published
2012-05-25—Filed